Versant Venture Capital VI, L.P.
LAVA Therapeutics N.V. · 10% Owner
Versant Venture Capital VI, L.P. is listed in filings as 10% Owner at LAVA Therapeutics N.V.. This profile follows SEC Form 4 activity through Oct 2, 2025, including sale activity. Recent filings connect the profile to LAVA Therapeutics N.V. (LVTX), LENZ Therapeutics, Inc. (LENZ), and Monte Rosa Therapeutics, Inc. (GLUE). The current snapshot covers public activity from Sep 13, 2024 to Oct 2, 2025. Reported amounts are shown as $329.9K to $294.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $5.8k123 shares | SellSep 30, 2025 | $47.01 | $4.88 | |
| $3M57.5k shares | SellSep 30, 2025 | $46.41 | $4.88 | |
| $2M34.4k shares | SellSep 30, 2025 | $45.35 | $4.88 | |
| $8.3k177 shares | SellSep 30, 2025 | $47.01 | $4.88 | |
| $4M83.1k shares | SellSep 30, 2025 | $46.41 | $4.88 | |
| $2M49.7k shares | SellSep 30, 2025 | $45.35 | $4.88 |